NexgenRx (TSXV:NXG) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:NXG NexgenRx Inc TSXV:NXG
55 GF Score
Price C$0.65
GF Value C$0.33
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is NexgenRx FFO?

FFO (Funds from operations) only applies to REITs.

TSXV:NXG
55GF Score
NexgenRx Inc TSXV:NXG
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is NexgenRx (TSXV:NXG) Overvalued in 2026?

Based on GuruFocus' analysis, NexgenRx stock appears to be overvalued. The current stock price of C$0.65 is trading 97% above its estimated GF Value™ of C$0.33. GuruFocus considers NexgenRx to be Significantly Overvalued.

Key valuation signals for TSXV:NXG:

  • FFO:
  • GF Value™: C$0.33 vs. price of C$0.65 (97% above fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the TSXV:NXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NexgenRx Business Description

Other Exchanges NEGXF:USA
Address 191 The West Mall, Suite 905, Toronto, ON, CAN, M9C 5L6
NexgenRx Inc administers, adjudicates, and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and also provides ancillary services. The various solutions offered by the company include: NexSys, a fully integrated rules-based adjudication platform for real-time processing of drug, dental, and extended health benefit claims; NexAdmin, which enables sponsors to take complete control of benefit plan administration; and NexPSPAssist, a service that helps Patient Support Programs (PSP) to optimize their deliverables to their manufacturer clients. The company has only one operating segment - benefits administration services.
55GF Score

Get the complete analysis for TSXV:NXG

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.65
Price
C$0.33
GF Value